We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Mr Heinrich Haas

Vice President of RNA Formulation and Drug Development

Heinrich Haas, Ph.D. has more than 18 years of experience in academic research and industrial pharmaceutical development. After he received his Ph.D. in physical chemistry, Dr. Haas researched lipid membranes and organized biomolecular systems. His professional focus is on colloidal/ nanoparticulate formulations for targeted drug delivery with therapeutic and diagnostic applications. Before joining BioNTech RNA Pharmaceuticals GmbH (former Ribological GmbH), he was responsible for a variety
of projects in biopharmaceutical research and development, ranging from the exploration of novel colloidal therapeutic and diagnostic carriers to up-scaling and development of market-compliant manufacturing methods for liposome products. After joining BioNTech RNA Pharmaceuticals GmbH in 2010, he helped build the formulation development and analytics unit,
which develops formulations for delivery of RNA and small molecules. Heinrich is also the Head of IMP manufacturing at BioNTech RNA Pharmaceuticals GmbH. He has an active record of publications in peer-reviewed journals (30+) and patent applications (10+) in the field of drug delivery.